Efficacy and safety of tranexamic acid on reducing blood loss in bilateral total knee arthroplasty

doi:10.3969/j.issn.2095-4344.2015.22.002

Abstract

Abstract:

BACKGROUND: The blood loss and the need of blood transfusion after bilateral total knee arthroplasty are very high. Therefore, the use of medicine such as tranexamic acid in total knee arthroplasty is overheated in recent years. Tranexamic acid has been proved to be able to decrease the blood loss after total knee arthroplasty, while the study of its use in bilateral total knee arthroplasty is seldom.
OBJECTIVE: To observe the effect and safety of tranexamic acid on perioperative blood loss and the change of hemoglobin in patients undergoing bilateral total knee arthroplasty.
METHODS: We selected 69 patients who received bilateral total knee arthroplasty and divided them into two different groups randomly. The patients in the experimental group were given 1 g of tranexamie acid dissolved in 100 mL of 5% glucose solution through intravenous infusion. Those in control group were only given 5% glucose solution 100 mL. Total blood loss, intraoperative blood loss, the hidden blood loss, amount of
postoperative drainage, the ratio of blood transfusion, hemoglobin, D-dimer, prothrombin time and activated partial thromboplastin time were studied and compared between the two groups. We also observed the incidence of thrombotic events between the two groups.
RESULTS AND CONCLUSION: The blood loss of the experimental group was significantly lower compared to the control group (t=2.194-2.908, P < 0.05). The blood transfusion rate of experimental group was significantly lower compared to the control group (χ2=5.219, P=0.022). The hemoglobin of the experimental group was significantly higher than that of the control group at 3 and 5 days after replacement (t=-3.481, 2.319, P < 0.05). No significant difference in prothrombin time and activated partial thromboplastin time was detectable between the two groups before and after replacement (P > 0.05). Thrombotic events were not visible in both groups. Venous ultrasonography in the lower extremity did not reveal deep venous thrombosis. Above results suggest that tranexamic acid can significantly reduce intraoperative blood loss in patients undergoing bilateral total knee arthroplasty, decreases the requirement of blood transfusion and the dynamic change of hemoglobin, and does not increase the risk of thrombosis.

Key words: Arthroplasty, Replacement, Knee, Tranexamic Acid, Venous Thrombosis

CLC Number:

R318

Wang Rong, Tian Shao-qi, Ha Cheng-zhi, Song Rui-xue, Sun Kang. Efficacy and safety of tranexamic acid on reducing blood loss in bilateral total knee arthroplasty[J]. Chinese Journal of Tissue Engineering Research, 2015, 19(22): 3451-3456.

Figures/Tables 4

References

[1] Memtsoudis S G, Sun X, Chiu YL, et al. Utilization of critical care services among patients undergoing total hip and knee arthroplasty: epidemiology and risk factors. Anesthesiology. 2012;117(1):107-116.
[2] Panteli M, Papakostidis C, Dahabreh Z, et al. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee. 2013;20(5):300-309.
[3] MacGillivray RG, Tarabichi SB, Hawari MF, et al. Tranexamic Acid to Reduce Blood Loss After Bilateral Total Knee Arthroplasty : A Prospective, Randomized Double Blind Study. J Arthroplasty. 2011;26(1):24-28.
[4] Cushner FD, Friedman RJ. Blood loss in total knee arthroplasty. Clin Orthop Relat Res. 1991;(269):98-101.
[5] Hynes MC, Calder P, Rosenfeld P, et al. The use of tranexamic acid to reduce blood loss during total hip arthroplasty: an observational study. Ann R Coll Surg Engl. 2005;87(2):99-101.
[6] MacGillivray RG, Tarabichi SB, Hawari MF, et al. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplasty. 2011;26(1):24-28.
[7] Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br. 2008;90(9): 1128-1136.
[8] Salido JA, Marin LA, Gomez LA, et al. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am. 2002;84-A(2):216-220.
[9] Sinclair KC, Clarke HD, Noble BN. Blood management in total knee arthroplasty: a comparison of techniques. Orthopedics. 2009;32(1):19.
[10] Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999;81(1):2-10.
[11] Tan J, Chen H, Liu Q, et al. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res.2013;184(2): 880-887.
[12] Petaja J, Myllynen P, Myllyla G, et al. Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand. 1987; 153(11-12):647-651.
[13] Klenerman L, Chakrabarti R, Mackie I, et al. Changes in haemostatic system after application of a tourniquet. Lancet. 1977;1(8019):970-972.
[14] Murkin JM. Lessons learned in antifibrinolytic therapy: The BART trial. Semin Cardiothorac Vasc Anesth. 2009;13(2): 127-131.
[15] Akizuki S, Yasukawa Y, Takizawa T. A new method of hemostasis for cementless total knee arthroplasty. Bull Hosp Jt Dis. 1997;56(4):222-224.
[16] 刘江俊,刘忠强,田少奇,等.氨甲环酸对减少单侧全膝关节置换术后出血的疗效观察[J].中国矫形外科杂志, 2014,22(23): 2144-2148.
[17] McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012;72(5):585-617.
[18] Tanaka N, Sakahashi H, Sato E, et al. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br. 2001;83(5):702-705.
[19] Xu Q, Yang Y, Shi P, et al. Repeated doses of intravenous tranexamic acid are effective and safe at reducing perioperative blood loss in total knee arthroplasty. Biosci Trends. 2014; 8(3):169-175.
[20] Maniar RN, Kumar G, Singhi T, et al. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res. 2012; 470(9):2605-2612.
[21] Irisson E, Hemon Y, Pauly V, et al. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthop Traumatol Surg Res.2012;98(5): 477-483.
[22] Oremus K, Sostaric S, Trkulja V, et al. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion. 2014;54(1):31-41.
[23] Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am. 2012; 94(13):1153-1159.
[24] Shemshaki H, Nourian SMA, Nourian N, et al. One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration. Arch Orthop Trauma Surg. 2015;135(4):573-588.
[25] Tan J, Chen H, Liu Q, et al. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res. 2013;184(2):880-887.
[26] Gandhi R, Evans HM, Mahomed SR, et al. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes. 2013;6:184.
[27] Zhang H, Chen J, Chen F, et al. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2012;20(9):1742-1752.
[28] Karaaslan F, Karao?lu S, Mermerkaya MU, et al. Reducing blood loss in simultaneous bilateral total knee arthroplasty: Combined intravenous-intra-articular tranexamic acid administration. A prospective randomized controlled trial. Knee. 2015;22(2):131-135.
[29] Qu Y. Effectiveness and Safety of Tranexamic Acid for Total Knee Arthroplasty: A Prospective Randomized Controlled Trial. Med Sci Monit. 2015;21:576-581.
[30] Wu Q, Zhang H, Liu S, et al. Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials. Eur J Orthop Surg. 2015;25(3):525-541.
[31] Karam JA, Bloomfield MR, DiIorio TM, et al. Evaluation of the Efficacy and Safety of Tranexamic Acid for Reducing Blood Loss in Bilateral Total Knee Arthroplasty. J Arthroplasty. 2014;29(3): 501-503.
[32] Poeran J, Rasul R, Suzuki S, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014;349:g4829.
[33] Sabatini L, Atzori F, Revello S, et al. Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. Arch Orthop Trauma Surg. 2014;134(11): 1609-1614.
[34] 马金辉,孙伟,高福强,等.关节腔注射氨甲环酸单侧全膝关节置换者的失血量及肢体周径变化:随机对照[J].中国组织工程研究, 2014,18(35):5577-5582.
[35] Alipour M, Tabari M, Keramati M, et al. Effectiveness of oral Tranexamic acid administration on blood loss after knee artroplasty: A randomized clinical trial. Transfus Apher Sci. 2013;49(3):574-577.
[36] Georgiadis AG, Muh SJ, Silverton CD, et al. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty. 2013;28(8 Suppl):78-82.
[37] Lee SH, Cho KY, Khurana S, et al. Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial. Knee Surg Sports Traumatol Arthrosc. 2013;21(11):2611-2617.
[38] Lozano M, Basora M, Peidro L, et al. Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang. 2008;95(1):39-44.
[39] Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth. 2003;90(5):596-599.
[40] Samujh C, Falls TD, Wessel R, et al. Decreased Blood Transfusion Following Revision Total Knee Arthroplasty Using Tranexamic Acid. J Arthroplasty. 2014;29(9):182-185.
[41] Zhang Y, Jin Y, Su L, et al. Clinic research on blood loss control by tranexamic acid during primary unilateral total knee replacement. Orthop J China. 2013;21:762-765.
[42] Li Y, Zhang W, Li H. Clinical Studies on Intra-articular Injections of Tranexamic Acid after Total Knee Arthroplasty. Med Philosophy. 2013;34:27-30.
[43] Moskal JT, Harris RN, Capps SG. Transfusion Cost Savings with Tranexamic Acid in Primary Total Knee Arthroplasty from 2009 to 2012. J Arthroplasty. 2015;30(3):365-368.
[44] Tuttle JR, Ritterman SA, Cassidy DB, et al. Cost Benefit Analysis of Topical Tranexamic Acid in Primary Total Hip and Knee Arthroplasty. J Arthroplasty. 2014;29(8):1512-1515.
[45] Chimento GF, Huff T, Ochsner JL, et al. An Evaluation of the Use of Topical Tranexamic Acid in Total Knee Arthroplasty. J Arthroplasty. 2013;28(8):74-77.
[46] Pachauri A, Acharya KK, Tiwari AK. The effect of tranexamic acid on hemoglobin levels during total knee arthroplasty. Am J Ther. 2014;21(5):366-370.
[47] Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354(4): 353-365.
[48] Bruce-Brand R, Dragomir R, Baker J, et al. Cerebrovascular infarction following bilateral total knee arthroplasty and tranexamic acid administration. Acta Orthop Belg. 2013;79(3): 351-354.
[49] Dahuja A, Dahuja G, Jaswal V, et al. A Prospective Study on Role of Tranexamic Acid in Reducing Postoperative Blood Loss in Total Knee Arthroplasty and Its Effect on Coagulation Profile. J Arthroplasty. 2014;29(4):733-735.

中国组织工程研究杂志出版内容重点：人工关节；骨植入物；脊柱；骨折；内固定；数字化骨科；组织工程